Considering the adverse effect of a MR diet, such as severe body weight loss observed in this study, NR4A2, a newly identified methionine-responsive oncogene with specifically high expression in clinical ESCC tissues, represents a compelling target for ESCC treatment in the presence of a normal diet. The gene discussed is NR4A2; the disease is esophageal squamous cell carcinoma.